Last reviewed · How we verify
Phyt.decandra + Melissa offic.
A herbal combination of Phytolacca decandra and Melissa officinalis that likely exerts anti-inflammatory and immunomodulatory effects through polyphenolic and volatile oil constituents.
A herbal combination of Phytolacca decandra and Melissa officinalis that likely exerts anti-inflammatory and immunomodulatory effects through polyphenolic and volatile oil constituents. Used for Phase 3 indication not publicly specified; likely immune or inflammatory condition based on constituent properties.
At a glance
| Generic name | Phyt.decandra + Melissa offic. |
|---|---|
| Also known as | homeopathic medicine complex |
| Sponsor | Universidade Federal do Rio de Janeiro |
| Drug class | Herbal combination / Botanical extract |
| Modality | Small molecule |
| Therapeutic area | Immunology / Inflammation |
| Phase | Phase 3 |
Mechanism of action
Phytolacca decandra (pokeweed) contains saponins and lectins with potential immunostimulatory properties, while Melissa officinalis (lemon balm) provides polyphenols and rosmarinic acid with antioxidant and anti-inflammatory activity. The combination may work synergistically to modulate immune responses and reduce inflammatory markers, though the exact mechanism in human disease remains incompletely characterized.
Approved indications
- Phase 3 indication not publicly specified; likely immune or inflammatory condition based on constituent properties
Common side effects
- Gastrointestinal disturbance
- Allergic reaction
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |